DRG 320

Surgical DRG

Other Endovascular Cardiac Valve Procedures without MCC

TypeSurgicalMDC05

What is MS-DRG 320?

MS-DRG 320 is a Surgical Medicare Severity Diagnosis Related Group under Major Diagnostic Category 05 (MDC 05) without a significant Complication or Comorbidity. For FY 2026 it carries a relative weight of 2.4053 with a geometric mean length of stay of 2.1 days and an arithmetic mean of 3 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.

Classification
Surgical DRG
Procedure-driven grouping
Linked Codes
0 diagnosis
38 procedure

FY 2026 Payment Data

Official values from Table 5 of the FY 2026 IPPS Final Rule (CMS).

Relative Weight
2.4053
Payment multiplier vs. average case (1.0)
Geometric Mean LOS
2.1 days
Used for transfer payment calculations
Arithmetic Mean LOS
3 days
Average length of stay
Post-Acute Transfer
No
Not subject to the transfer policy

Related MS-DRGs in This Severity Group

The same clinical condition is split into separate DRGs by complication severity. MCC pays more than CC, which pays more than no CC/MCC.

DRGTitleRel. WeightGMLOS
319Other Endovascular Cardiac Valve Procedures with MCC4.46297.4 days
320Other Endovascular Cardiac Valve Procedures without MCCThis page2.40532.1 days

Linked ICD-10-PCS Procedure Mappings

  • 025F3ZZ

    Destruction of Aortic Valve, Percutaneous Approach

    BillableSection 0
  • 025G3ZZ

    Destruction of Mitral Valve, Percutaneous Approach

    BillableSection 0
  • 025H3ZZ

    Destruction of Pulmonary Valve, Percutaneous Approach

    BillableSection 0
  • 025J3ZZ

    Destruction of Tricuspid Valve, Percutaneous Approach

    BillableSection 0
  • 027F0ZZ

    Dilation of Aortic Valve, Open Approach

    BillableSection 0
  • 027G0ZZ

    Dilation of Mitral Valve, Open Approach

    BillableSection 0
  • 027H0ZZ

    Dilation of Pulmonary Valve, Open Approach

    BillableSection 0
  • 027J0ZZ

    Dilation of Tricuspid Valve, Open Approach

    BillableSection 0
  • 02BF3ZZ

    Excision of Aortic Valve, Percutaneous Approach

    BillableSection 0
  • 02BG3ZZ

    Excision of Mitral Valve, Percutaneous Approach

    BillableSection 0
  • 02BH3ZZ

    Excision of Pulmonary Valve, Percutaneous Approach

    BillableSection 0
  • 02BJ3ZZ

    Excision of Tricuspid Valve, Percutaneous Approach

    BillableSection 0
  • 02QF3ZJ

    Repair Aortic Valve created from Truncal Valve, Percutaneous Approach

    BillableSection 0
  • 02QF3ZZ

    Repair Aortic Valve, Percutaneous Approach

    BillableSection 0
  • 02QG3ZE

    Repair Mitral Valve created from Left Atrioventricular Valve, Percutaneous Approach

    BillableSection 0
  • 02QG3ZZ

    Repair Mitral Valve, Percutaneous Approach

    BillableSection 0
  • 02QH3ZZ

    Repair Pulmonary Valve, Percutaneous Approach

    BillableSection 0
  • 02QJ3ZG

    Repair Tricuspid Valve created from Right Atrioventricular Valve, Percutaneous Approach

    BillableSection 0
  • 02QJ3ZZ

    Repair Tricuspid Valve, Percutaneous Approach

    BillableSection 0
  • 02TH3ZZ

    Resection of Pulmonary Valve, Percutaneous Approach

    BillableSection 0
  • 02VG3ZZ

    Restriction of Mitral Valve, Percutaneous Approach

    BillableSection 0
  • 02WF38Z

    Revision of Zooplastic Tissue in Aortic Valve, Percutaneous Approach

    BillableSection 0
  • 02WF3JZ

    Revision of Synthetic Substitute in Aortic Valve, Percutaneous Approach

    BillableSection 0
  • 02WF3KZ

    Revision of Nonautologous Tissue Substitute in Aortic Valve, Percutaneous Approach

    BillableSection 0
  • 02WG37Z

    Revision of Autologous Tissue Substitute in Mitral Valve, Percutaneous Approach

    BillableSection 0
  • 02WG38Z

    Revision of Zooplastic Tissue in Mitral Valve, Percutaneous Approach

    BillableSection 0
  • 02WG3JZ

    Revision of Synthetic Substitute in Mitral Valve, Percutaneous Approach

    BillableSection 0
  • 02WG3KZ

    Revision of Nonautologous Tissue Substitute in Mitral Valve, Percutaneous Approach

    BillableSection 0
  • 02WH37Z

    Revision of Autologous Tissue Substitute in Pulmonary Valve, Percutaneous Approach

    BillableSection 0
  • 02WH38Z

    Revision of Zooplastic Tissue in Pulmonary Valve, Percutaneous Approach

    BillableSection 0
  • 02WH3JZ

    Revision of Synthetic Substitute in Pulmonary Valve, Percutaneous Approach

    BillableSection 0
  • 02WH3KZ

    Revision of Nonautologous Tissue Substitute in Pulmonary Valve, Percutaneous Approach

    BillableSection 0
  • 02WJ37Z

    Revision of Autologous Tissue Substitute in Tricuspid Valve, Percutaneous Approach

    BillableSection 0
  • 02WJ38Z

    Revision of Zooplastic Tissue in Tricuspid Valve, Percutaneous Approach

    BillableSection 0
  • 02WJ3JZ

    Revision of Synthetic Substitute in Tricuspid Valve, Percutaneous Approach

    BillableSection 0
  • 02WJ3KZ

    Revision of Nonautologous Tissue Substitute in Tricuspid Valve, Percutaneous Approach

    BillableSection 0
  • X28F3VA

    Division of Aortic Valve using Intraluminal Bioprosthetic Valve Leaflet Splitting Technology in Existing Valve, Percutaneous Approach, New Technology Group 10

    BillableSection X
  • X28F3WB

    Division of Aortic Valve using Leaflet Laceration, Radiofrequency Energy, Percutaneous Approach, New Technology Group 11

    BillableSection X